Center for Identification and Study of Individuals with Atypical Diabetes Mellitus (U54)
This Funding Opportunity Announcement (FOA) invites applications for a Center for Identification and Study of Individuals with Atypical Diabetes Mellitus (U54). The purpose of this Center is to: foster the study of individuals with rare/atypical forms of diabetes mellitus; identify and analyze phenotypic and genotypic defects that may provide insights into more common, heterogeneous forms of Type 2 diabetes mellitus (T2DM) in the general population; and develop a community resource to advance research in this area through the collection and dissemination of data and samples for access by the broad research community. To ac...
Source: NIDDK Funding Opportunities - May 16, 2017 Category: Endocrinology Source Type: funding
Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R21)
Funding Opportunity PA-17-282 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to invite applications to support innovative research to improve our understanding of innate and adaptive immune dysregulation caused by Type 2 diabetes mellitus (DM) and pre-diabetes that causes increased risk of latent tuberculosis (TB) re-activation and more severe active TB disease with more frequent treatment failure/relapse and death in the context of HIV co-infection. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 12, 2017 Category: Research Source Type: funding
Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R01)
Funding Opportunity PA-17-283 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications to support innovative research to improve our understanding of innate and adaptive immune dysregulation caused by Type 2 diabetes mellitus (DM) and pre-diabetes that causes increased risk of latent tuberculosis (TB) re-activation and more severe active TB disease with more frequent treatment failure/relapse and death in the context of HIV co-infection. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 12, 2017 Category: Research Source Type: funding
Request for Letters of Intent: Glucose Responsive Insulin Discovery and Validation
Letter of Interest Deadline: July 11, 2014 JDRF, the world’s leading non-profit organization with the mission to cure, treat and prevent type 1 diabetes (T1D), invites Letters of Intent (LOI) for the discovery and validation of novel glucose responsive insulin (GRI) drugs for better treatment of insulin-dependent diabetes mellitus (IDDM) and reducing the burden of daily management of the disease, particularly T1D. Proposals (supported by strong rationale and/or preliminary data) will be considered for a maximum budget of up to $500,000* per year for up to 3 years of funding (including 10% indirect ...
Source: ScanGrants feed - May 27, 2014 Category: Research Authors: JDRF Source Type: funding
Request for Proposals: 2013 ASPIRE Awards in Adult Vaccine Research
Mission The mission of the 2013 ASPIRE Awards in Adult Vaccine Research is to advance medical knowledge to better understand the burden of pneumococcal disease in adults. The burden of pneumococcal disease in the general adult population has been extensively studied; however, it is not well-defined in special populations, including subgroups with underlying disease comorbidities and/or those living in long-term community settings. Pfizer invites investigators to apply for the 2013 ASPIRE Awards in Adult Vaccine Research through submission of innovative research proposals for evaluation of the epidemiology ...
Source: ScanGrants feed - May 1, 2013 Category: Research Authors: Pfizer Source Type: funding
